Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03850002

Lung Clearance Index and Lung Allograft Dysfunction

Lung Clearance Index for the Early Detection and Monitoring of Lung Allograft Dysfunction After Adult Lung Transplantation

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this project is to evaluate the ability of the lung clearance index (LCI) to detect early chronic lung allograft failure (CLAD) in adult lung transplant recipients over a period of 3 years.

Detailed description

This single center study consists of three parts: 1. Characterisation of the Zurich lung transplant cohort regarding CLAD status and pulmonary function impairment (cross-sectional, study part I) 2. Evaluation of test-retest reliability of LCI in 20 clinically stable lung transplant recipients during three consecutive study visits (study part II) 3. Prospective cohort study to test the ability of LCI to detect early CLAD in patients without prior CLAD (study part III)

Conditions

Interventions

TypeNameDescription
OTHEREarly detection of CLAD by Lung Clearance Index (LCI)Lung transplant candidates without prior CLAD (evaluated in study part I) will be followed over a period of 3 years to evaluate the potential of LCI to detect early CLAD

Timeline

Start date
2019-03-01
Primary completion
2022-12-31
Completion
2023-09-30
First posted
2019-02-21
Last updated
2019-07-25

Source: ClinicalTrials.gov record NCT03850002. Inclusion in this directory is not an endorsement.